Chagas Disease Partnership Will Deliver Safe, Easy-to-Use Treatment for Children
July 21st, 2008 | Market Watch
A new partnership between Lafepe and DNDi will make available the first pediatric formulation of benznidazole to patients by the end of 2009. The drug will be sold at cost, with no profit to the institutions involved in its development, and will be available for distribution worldwide.
Leave a Comment